Hirth Peter
SEC insider (Form 3/4/5 filer). CIK 0001813780. Director at TRex Bio, Inc. (TRXB) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Hirth Peter has filed insider reports for
- TRex Bio, Inc. (TRXB): Director
- Aligos Therapeutics, Inc. (ALGS): Director
- IO Biotech, Inc. (IOBT): Director
Hirth Peter
CIK: 0001813780
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 8, 2026TRXB
TRex Bio, Inc.
AwardDirectStock Option (Right to Buy)
17.5K shares- - Jun 25, 2026ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5.9K shares- - Jun 25, 2025ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
5.9K shares- - Jun 5, 2025IOBT
IO Biotech, Inc.
AwardDirectStock Option (Right to Buy)
35.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 8, 2026 |  TRXB TRex Bio, Inc. | Award Stock Option (Right to Buy) | 17,500 | - | - | Direct |
| Jun 25, 2026 |  ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,860 | - | - | Direct |
| Jun 25, 2025 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 5,860 | - | - | Direct |
| Jun 5, 2025 |  IOBT IO Biotech, Inc. | Award Stock Option (Right to Buy) | 35,144 | - | - | Direct |
1-4 of 4 transactions